Article Details
Retrieved on: 2018-05-02 14:56:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Advent Life Sciences, Arix Bioscience, Bay City Capital, Canaan Partners and <b>Sofinnova Ventures</b> are among the company's investors that so far provided about US$105m venture capital. The series B round roughly one year ago raked in US$65m. The IPO and series B proceeds taken together are ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here